Randomised double blind controlled trial of cyclosporin in multiple sclerosis.

P Rudge,J C Koetsier,J Mertin, J O Mispelblom Beyer, H K Van Walbeek, R Clifford Jones, J Harrison, K Robinson,B Mellein, T Poole

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY(1989)

引用 95|浏览4
暂无评分
摘要
In a 2 year double blind controlled trial of cyclosporin against placebo in multiple sclerosis conducted at two centres there was a beneficial effect of the therapy upon the progression of the disease, relapse rate and relapse severity at one of the centres where the patients received a mean dose of 7.2 mg/kg/day. This beneficial effect was not seen in the other centre where a lower dose (mean 5 mg/kg/day) was given. Reduction in clinical progression was accompanied by decreased IgG synthesis in the central nervous system. Side effects included hypertension, renal insufficiency and anaemia and were of such severity to preclude the use of cyclosporin in a high enough dose to alter the course of the disease.
更多
查看译文
关键词
central nervous system,side effect,controlled trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要